FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons

Nobumasa Takasugi, Tomoki Sasaki, Ihori Ebinuma, Satoko Osawa, Hayato Isshiki, Koji Takeo, Taisuke Tomita, Takeshi Iwatsubo

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Sphingosine-1-phosphate (S1P) is a pluripotent lipophilic mediator working as a ligand for G-protein coupled S1P receptors (S1PR), which is currently highlighted as a therapeutic target for autoimmune diseases including relapsing forms of multiple sclerosis. Sphingosine related compounds, FTY720 and KRP203 known as S1PR modulators, are phosphorylated by sphingosine kinase 2 (SphK2) to yield the active metabolites FTY720-P and KRP203-P, which work as functional antagonists for S1PRs. Here we report that FTY720 and KRP203 decreased production of Amyloid-β peptide (Aβ), a pathogenic proteins causative for Alzheimer disease (AD), in cultured neuronal cells. Pharmacological analyses suggested that the mechanism of FTY720-mediated Aβ decrease in cells was independent of known downstream signaling pathways of S1PRs. Unexpectedly, 6-days treatment of APP transgenic mice with FTY720 resulted in a decrease in Aβ40, but an increase in Aβ42 levels in brains. These results suggest that S1PR modulators are novel type of regulators for Aβ metabolisms that are active in vitro and in vivo.

Original languageEnglish
Article numbere64050
JournalPLoS One
Volume8
Issue number5
DOIs
Publication statusPublished - May 7 2013
Externally publishedYes

Fingerprint

sphingosine
Sphingosine
Lysosphingolipid Receptors
amyloid
Amyloid
Neurons
neurons
Modulators
receptors
phosphates
autoimmune diseases
sclerosis
Alzheimer disease
Metabolites
G-proteins
GTP-Binding Proteins
Metabolism
Transgenic Mice
Autoimmune Diseases
Multiple Sclerosis

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Takasugi, N., Sasaki, T., Ebinuma, I., Osawa, S., Isshiki, H., Takeo, K., ... Iwatsubo, T. (2013). FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons. PLoS One, 8(5), [e64050]. https://doi.org/10.1371/journal.pone.0064050

FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons. / Takasugi, Nobumasa; Sasaki, Tomoki; Ebinuma, Ihori; Osawa, Satoko; Isshiki, Hayato; Takeo, Koji; Tomita, Taisuke; Iwatsubo, Takeshi.

In: PLoS One, Vol. 8, No. 5, e64050, 07.05.2013.

Research output: Contribution to journalArticle

Takasugi, N, Sasaki, T, Ebinuma, I, Osawa, S, Isshiki, H, Takeo, K, Tomita, T & Iwatsubo, T 2013, 'FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons', PLoS One, vol. 8, no. 5, e64050. https://doi.org/10.1371/journal.pone.0064050
Takasugi, Nobumasa ; Sasaki, Tomoki ; Ebinuma, Ihori ; Osawa, Satoko ; Isshiki, Hayato ; Takeo, Koji ; Tomita, Taisuke ; Iwatsubo, Takeshi. / FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons. In: PLoS One. 2013 ; Vol. 8, No. 5.
@article{91f7274340304dd5b79297fc56bb8f4d,
title = "FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons",
abstract = "Sphingosine-1-phosphate (S1P) is a pluripotent lipophilic mediator working as a ligand for G-protein coupled S1P receptors (S1PR), which is currently highlighted as a therapeutic target for autoimmune diseases including relapsing forms of multiple sclerosis. Sphingosine related compounds, FTY720 and KRP203 known as S1PR modulators, are phosphorylated by sphingosine kinase 2 (SphK2) to yield the active metabolites FTY720-P and KRP203-P, which work as functional antagonists for S1PRs. Here we report that FTY720 and KRP203 decreased production of Amyloid-β peptide (Aβ), a pathogenic proteins causative for Alzheimer disease (AD), in cultured neuronal cells. Pharmacological analyses suggested that the mechanism of FTY720-mediated Aβ decrease in cells was independent of known downstream signaling pathways of S1PRs. Unexpectedly, 6-days treatment of APP transgenic mice with FTY720 resulted in a decrease in Aβ40, but an increase in Aβ42 levels in brains. These results suggest that S1PR modulators are novel type of regulators for Aβ metabolisms that are active in vitro and in vivo.",
author = "Nobumasa Takasugi and Tomoki Sasaki and Ihori Ebinuma and Satoko Osawa and Hayato Isshiki and Koji Takeo and Taisuke Tomita and Takeshi Iwatsubo",
year = "2013",
month = "5",
day = "7",
doi = "10.1371/journal.pone.0064050",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons

AU - Takasugi, Nobumasa

AU - Sasaki, Tomoki

AU - Ebinuma, Ihori

AU - Osawa, Satoko

AU - Isshiki, Hayato

AU - Takeo, Koji

AU - Tomita, Taisuke

AU - Iwatsubo, Takeshi

PY - 2013/5/7

Y1 - 2013/5/7

N2 - Sphingosine-1-phosphate (S1P) is a pluripotent lipophilic mediator working as a ligand for G-protein coupled S1P receptors (S1PR), which is currently highlighted as a therapeutic target for autoimmune diseases including relapsing forms of multiple sclerosis. Sphingosine related compounds, FTY720 and KRP203 known as S1PR modulators, are phosphorylated by sphingosine kinase 2 (SphK2) to yield the active metabolites FTY720-P and KRP203-P, which work as functional antagonists for S1PRs. Here we report that FTY720 and KRP203 decreased production of Amyloid-β peptide (Aβ), a pathogenic proteins causative for Alzheimer disease (AD), in cultured neuronal cells. Pharmacological analyses suggested that the mechanism of FTY720-mediated Aβ decrease in cells was independent of known downstream signaling pathways of S1PRs. Unexpectedly, 6-days treatment of APP transgenic mice with FTY720 resulted in a decrease in Aβ40, but an increase in Aβ42 levels in brains. These results suggest that S1PR modulators are novel type of regulators for Aβ metabolisms that are active in vitro and in vivo.

AB - Sphingosine-1-phosphate (S1P) is a pluripotent lipophilic mediator working as a ligand for G-protein coupled S1P receptors (S1PR), which is currently highlighted as a therapeutic target for autoimmune diseases including relapsing forms of multiple sclerosis. Sphingosine related compounds, FTY720 and KRP203 known as S1PR modulators, are phosphorylated by sphingosine kinase 2 (SphK2) to yield the active metabolites FTY720-P and KRP203-P, which work as functional antagonists for S1PRs. Here we report that FTY720 and KRP203 decreased production of Amyloid-β peptide (Aβ), a pathogenic proteins causative for Alzheimer disease (AD), in cultured neuronal cells. Pharmacological analyses suggested that the mechanism of FTY720-mediated Aβ decrease in cells was independent of known downstream signaling pathways of S1PRs. Unexpectedly, 6-days treatment of APP transgenic mice with FTY720 resulted in a decrease in Aβ40, but an increase in Aβ42 levels in brains. These results suggest that S1PR modulators are novel type of regulators for Aβ metabolisms that are active in vitro and in vivo.

UR - http://www.scopus.com/inward/record.url?scp=84877113548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877113548&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0064050

DO - 10.1371/journal.pone.0064050

M3 - Article

C2 - 23667698

AN - SCOPUS:84877113548

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e64050

ER -